The topic was discussed during a lecture at the 43rd CIOSP, the largest dentistry congress in Latin America, focusing on scientific evidence and the impacts of Anvisa's new regulations on dental practice in the treatment of orofacial pain.

The topic was discussed during a lecture at the 43rd CIOSP, the largest dentistry congress in Latin America, focusing on scientific evidence and the impacts of Anvisa's new regulation on dental practice in the treatment of orofacial pain

CBN and CBC stand out as minor cannabinoids with therapeutic potential to improve sleep, relieve pain, and modulate inflammatory processes

Dr. Jimmy Fardim and Dr. Rafaela da Rosa explain how microbiota, endocannabinoid system, and cannabis connect in building truly integrative health

Scientific Committee maintains technical rigor and focuses on a forward-looking program in the 5th edition of the event in São Paulo

CFO supports dentists among authorized professionals to prescribe safely and with quality

Debate on the Sechat Portal podcast compares Rivotril and medical cannabis, highlighting effectiveness, safety, side effects, and differences between acute use and long-term treatment

Neurosurgeon explains on Deusa Cast podcast how cannabis acts on pain, mood, and multiple symptoms, functioning as a multifunctional therapeutic tool

Clinical study indicates that continuous use of cannabidiol may contribute to reducing blood pressure in individuals with hypertension

Study points to an increase in cases of cannabinoid hyperemesis syndrome, a condition associated with prolonged cannabis use and characterized by intense nausea and vomiting

National survey shows unprecedented reversal: consumption decreases among boys and nearly quadruples among girls aged 14 to 17 in ten years

Preclinical study suggests CBD may reduce intestinal spasms and diarrhea, with a direct effect on gastrointestinal motility